ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.

Schuster, Michael W; Rigas, James R; Orlov, Sergey V; Milovanovic, Branislav M; Prabhash, Kumar; Smith, Jeffrey T

Results

eNauka > Results > ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.

Title:	ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.
Authors:	Schuster, Michael W; Rigas, James R; Orlov, Sergey V; Milovanovic, Branislav M; Prabhash, Kumar; Smith, Jeffrey T
Issue Date:	2010
Publication:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X Journal of Clinical Oncology Search Idenfier
Type:	Conference Paper
Collation:	vol. 28 br. 15
WoS-ID:	000208852005011
URI:	https://enauka.gov.rs/handle/123456789/831235
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM